mci 9038 has been researched along with Arrhythmia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pötzsch, B | 1 |
| Epperla, N; Jayarangaiah, A | 1 |
1 review(s) available for mci 9038 and Arrhythmia
| Article | Year |
|---|---|
[Anticoagulation].
Topics: Administration, Oral; Anticoagulants; Antithrombins; Arginine; Arrhythmias, Cardiac; Blood Coagulation Tests; Factor Xa Inhibitors; Hemorrhage; Heparin; Heparinoids; Hirudins; Humans; Infusions, Intravenous; Orthopedic Procedures; Peptide Fragments; Pipecolic Acids; Postoperative Complications; Pulmonary Embolism; Recombinant Proteins; Risk Factors; Secondary Prevention; Sulfonamides; Thromboembolism; Treatment Outcome; Venous Thrombosis; Vitamin K | 2013 |
1 other study(ies) available for mci 9038 and Arrhythmia
| Article | Year |
|---|---|
Early recognition is the key to success: pulseless electrical activity (PEA) as a manifestation of heparin-induced anaphylactoid reaction.
Topics: Anticoagulants; Arginine; Arrhythmias, Cardiac; Cardiopulmonary Resuscitation; Early Diagnosis; Heart Valve Prosthesis Implantation; Heparin; Humans; Male; Middle Aged; Mitral Valve; Pipecolic Acids; Platelet Count; Platelet Function Tests; Sulfonamides; Thrombocytopenia; Treatment Outcome | 2015 |